Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Erythrocyte Membrane | 21 | 2011 | 442 | 2.010 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 15 | 2013 | 153 | 1.140 |
Why?
|
Genetic Diseases, Inborn | 3 | 2019 | 587 | 0.850 |
Why?
|
Cytoskeleton | 7 | 2012 | 1185 | 0.710 |
Why?
|
Ankyrins | 5 | 2010 | 128 | 0.710 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 7 | 2009 | 437 | 0.550 |
Why?
|
Cell Membrane | 15 | 2013 | 3749 | 0.510 |
Why?
|
Membrane Lipids | 10 | 1996 | 249 | 0.500 |
Why?
|
Nitric Oxide Synthase | 7 | 2005 | 915 | 0.490 |
Why?
|
Capacity Building | 1 | 2017 | 248 | 0.490 |
Why?
|
Diffusion | 15 | 2011 | 832 | 0.470 |
Why?
|
Receptors, Transferrin | 5 | 2005 | 296 | 0.440 |
Why?
|
Calcium | 16 | 2010 | 5755 | 0.440 |
Why?
|
Elliptocytosis, Hereditary | 2 | 2011 | 30 | 0.430 |
Why?
|
Spectrin | 5 | 2010 | 177 | 0.430 |
Why?
|
Erythrocytes, Abnormal | 4 | 2011 | 125 | 0.420 |
Why?
|
Membrane Proteins | 19 | 2015 | 7882 | 0.420 |
Why?
|
Microscopy, Fluorescence | 16 | 2010 | 2700 | 0.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2015 | 3595 | 0.410 |
Why?
|
Genetic Variation | 4 | 2015 | 6542 | 0.400 |
Why?
|
Erythrocytes | 9 | 1999 | 2455 | 0.390 |
Why?
|
Pseudomonas aeruginosa | 6 | 2009 | 1219 | 0.390 |
Why?
|
Computational Biology | 2 | 2014 | 3519 | 0.390 |
Why?
|
Introns | 2 | 2011 | 992 | 0.380 |
Why?
|
International Cooperation | 1 | 2017 | 1420 | 0.370 |
Why?
|
Endothelium, Vascular | 13 | 2007 | 4459 | 0.350 |
Why?
|
Complement C3b | 1 | 2009 | 106 | 0.340 |
Why?
|
Research Design | 2 | 2015 | 5984 | 0.340 |
Why?
|
T-Lymphocytes | 11 | 2010 | 10183 | 0.330 |
Why?
|
Disease | 1 | 2014 | 680 | 0.330 |
Why?
|
Faculty, Medical | 1 | 2017 | 1181 | 0.330 |
Why?
|
Cell Adhesion Molecules | 4 | 2008 | 1602 | 0.320 |
Why?
|
Endocytosis | 5 | 2009 | 985 | 0.320 |
Why?
|
Membrane Fluidity | 10 | 1996 | 73 | 0.310 |
Why?
|
Caveolin 1 | 2 | 2009 | 263 | 0.310 |
Why?
|
Multifactorial Inheritance | 1 | 2014 | 1195 | 0.290 |
Why?
|
Cell Adhesion | 12 | 2008 | 3144 | 0.290 |
Why?
|
Transferases (Other Substituted Phosphate Groups) | 4 | 2007 | 34 | 0.280 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 3 | 2011 | 379 | 0.280 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2008 | 2540 | 0.270 |
Why?
|
Genome, Human | 4 | 2016 | 4420 | 0.260 |
Why?
|
Calmodulin | 2 | 2003 | 209 | 0.260 |
Why?
|
Aquaporins | 2 | 2013 | 174 | 0.260 |
Why?
|
Receptors, Cell Surface | 5 | 2007 | 2865 | 0.260 |
Why?
|
Schistosoma mansoni | 3 | 1993 | 149 | 0.260 |
Why?
|
Models, Statistical | 3 | 2014 | 5101 | 0.260 |
Why?
|
Jurkat Cells | 5 | 2010 | 743 | 0.250 |
Why?
|
Models, Genetic | 2 | 2014 | 3493 | 0.250 |
Why?
|
Electricity | 2 | 1996 | 182 | 0.250 |
Why?
|
Cell Line | 25 | 2013 | 16000 | 0.230 |
Why?
|
Kinetics | 15 | 2006 | 6476 | 0.230 |
Why?
|
Health Personnel | 1 | 2017 | 3219 | 0.230 |
Why?
|
Pseudomonas Infections | 4 | 2009 | 613 | 0.220 |
Why?
|
Cystic Fibrosis | 2 | 2009 | 1178 | 0.220 |
Why?
|
Pituitary Gland | 3 | 1995 | 665 | 0.220 |
Why?
|
Lipid Bilayers | 7 | 2013 | 381 | 0.220 |
Why?
|
Protein Interaction Mapping | 1 | 2006 | 627 | 0.220 |
Why?
|
Alleles | 4 | 2022 | 6933 | 0.220 |
Why?
|
MicroRNAs | 4 | 2013 | 3751 | 0.210 |
Why?
|
Essential Tremor | 1 | 2004 | 130 | 0.210 |
Why?
|
Phospholipids | 6 | 2000 | 784 | 0.210 |
Why?
|
Fluorescent Dyes | 13 | 2006 | 1917 | 0.200 |
Why?
|
Fluorescein-5-isothiocyanate | 9 | 2006 | 225 | 0.200 |
Why?
|
Biomedical Research | 1 | 2017 | 3309 | 0.200 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4805 | 0.190 |
Why?
|
Molecular Probes | 3 | 2007 | 316 | 0.180 |
Why?
|
Membrane Microdomains | 4 | 2009 | 203 | 0.180 |
Why?
|
Recombinant Proteins | 5 | 2008 | 6621 | 0.180 |
Why?
|
Genome-Wide Association Study | 4 | 2016 | 12262 | 0.180 |
Why?
|
Electromagnetic Fields | 2 | 1999 | 298 | 0.170 |
Why?
|
Delivery of Health Care | 1 | 2017 | 5321 | 0.170 |
Why?
|
Microscopy, Video | 4 | 2001 | 245 | 0.170 |
Why?
|
Gene Frequency | 3 | 2016 | 3587 | 0.160 |
Why?
|
Calcium Signaling | 2 | 2003 | 721 | 0.160 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2013 | 437 | 0.160 |
Why?
|
Intercellular Junctions | 2 | 2015 | 203 | 0.160 |
Why?
|
Humans | 98 | 2022 | 744366 | 0.160 |
Why?
|
Epithelial Cells | 3 | 2009 | 3690 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 805 | 0.160 |
Why?
|
Cattle | 10 | 2012 | 3922 | 0.160 |
Why?
|
Protein Transport | 6 | 2015 | 1988 | 0.160 |
Why?
|
Proteins | 4 | 2011 | 6100 | 0.150 |
Why?
|
Biophysical Phenomena | 5 | 1999 | 327 | 0.150 |
Why?
|
Electric Stimulation | 2 | 2004 | 1767 | 0.150 |
Why?
|
Integrins | 2 | 2012 | 846 | 0.150 |
Why?
|
Lysophosphatidylcholines | 2 | 1988 | 81 | 0.150 |
Why?
|
RNA, Small Interfering | 8 | 2015 | 3505 | 0.150 |
Why?
|
Biophysics | 5 | 1999 | 383 | 0.150 |
Why?
|
Genomics | 4 | 2014 | 5717 | 0.150 |
Why?
|
Macrophage Activation | 1 | 2000 | 560 | 0.140 |
Why?
|
Lactase | 1 | 2016 | 69 | 0.140 |
Why?
|
Anemia, Sickle Cell | 4 | 2007 | 1020 | 0.140 |
Why?
|
Cytomegalovirus | 2 | 2013 | 733 | 0.140 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 2 | 1995 | 36 | 0.140 |
Why?
|
Fibronectins | 2 | 2000 | 726 | 0.140 |
Why?
|
Contact Inhibition | 1 | 2015 | 48 | 0.140 |
Why?
|
RNA Splicing | 2 | 2011 | 908 | 0.140 |
Why?
|
Fluorescence Polarization | 4 | 1998 | 132 | 0.140 |
Why?
|
Thyrotropin-Releasing Hormone | 2 | 1995 | 147 | 0.140 |
Why?
|
Nuclear Lamina | 2 | 2013 | 46 | 0.130 |
Why?
|
Major Histocompatibility Complex | 2 | 2016 | 936 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1366 | 0.130 |
Why?
|
Blood Proteins | 3 | 1999 | 1124 | 0.130 |
Why?
|
Animals | 43 | 2015 | 168768 | 0.130 |
Why?
|
Biological Transport | 7 | 2002 | 2120 | 0.130 |
Why?
|
Actomyosin | 1 | 2015 | 111 | 0.130 |
Why?
|
Models, Biological | 8 | 2012 | 9584 | 0.130 |
Why?
|
Algorithms | 4 | 2012 | 13882 | 0.130 |
Why?
|
Freeze Fracturing | 2 | 2009 | 68 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2014 | 15520 | 0.120 |
Why?
|
Lymphocyte Activation | 7 | 2006 | 5524 | 0.120 |
Why?
|
Tumor Cells, Cultured | 7 | 2000 | 6313 | 0.120 |
Why?
|
Zygote | 2 | 1996 | 116 | 0.120 |
Why?
|
Rwanda | 1 | 2017 | 703 | 0.120 |
Why?
|
Neurofibromin 2 | 1 | 2015 | 267 | 0.120 |
Why?
|
Nitric Oxide Synthase Type III | 6 | 2005 | 689 | 0.120 |
Why?
|
Erythrocyte Aggregation | 2 | 1996 | 36 | 0.120 |
Why?
|
Receptor Aggregation | 3 | 2008 | 80 | 0.120 |
Why?
|
Electric Stimulation Therapy | 1 | 2000 | 605 | 0.120 |
Why?
|
Cytoskeletal Proteins | 3 | 2015 | 1364 | 0.120 |
Why?
|
Protein Binding | 6 | 2008 | 9384 | 0.120 |
Why?
|
Calcium Channels | 5 | 2004 | 622 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 17446 | 0.110 |
Why?
|
Genome | 2 | 2013 | 1807 | 0.110 |
Why?
|
Anonymous Testing | 1 | 2013 | 8 | 0.110 |
Why?
|
Phosphorylation | 13 | 2013 | 8436 | 0.110 |
Why?
|
Cell Movement | 3 | 2006 | 5218 | 0.110 |
Why?
|
Colchicine | 1 | 1994 | 244 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 6 | 2009 | 3773 | 0.110 |
Why?
|
Microsatellite Repeats | 2 | 2013 | 802 | 0.110 |
Why?
|
Virus Release | 1 | 2013 | 39 | 0.110 |
Why?
|
Fertilization | 1 | 1994 | 196 | 0.110 |
Why?
|
Names | 1 | 2013 | 52 | 0.110 |
Why?
|
Membranes | 1 | 1993 | 173 | 0.110 |
Why?
|
Vinblastine | 1 | 1994 | 502 | 0.110 |
Why?
|
Bacterial Proteins | 5 | 2007 | 3854 | 0.110 |
Why?
|
Umbilical Veins | 3 | 2007 | 433 | 0.110 |
Why?
|
HLA Antigens | 3 | 1988 | 1382 | 0.110 |
Why?
|
Water | 1 | 1999 | 1395 | 0.110 |
Why?
|
Integrin alpha6 | 1 | 2012 | 30 | 0.110 |
Why?
|
Diffusion of Innovation | 1 | 2017 | 725 | 0.100 |
Why?
|
Cells, Cultured | 14 | 2015 | 19233 | 0.100 |
Why?
|
Cell Compartmentation | 2 | 2011 | 402 | 0.100 |
Why?
|
Chromosomes, Human, Y | 1 | 2013 | 148 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2012 | 2916 | 0.100 |
Why?
|
Fibroblasts | 2 | 2002 | 4162 | 0.100 |
Why?
|
Receptors, LDL | 1 | 1994 | 476 | 0.100 |
Why?
|
Prenatal Diagnosis | 1 | 2019 | 1236 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2016 | 914 | 0.100 |
Why?
|
Respiratory Mucosa | 2 | 2007 | 427 | 0.100 |
Why?
|
Estradiol | 1 | 1999 | 2020 | 0.100 |
Why?
|
Receptors, Immunologic | 3 | 2012 | 1423 | 0.100 |
Why?
|
Microscopy, Electron | 3 | 2009 | 2646 | 0.100 |
Why?
|
Viruses | 1 | 2015 | 375 | 0.100 |
Why?
|
Biopolymers | 3 | 1997 | 189 | 0.100 |
Why?
|
Program Development | 1 | 2017 | 1316 | 0.100 |
Why?
|
Blastocyst | 1 | 1994 | 424 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 4 | 2007 | 1988 | 0.090 |
Why?
|
Evolution, Molecular | 2 | 2010 | 1939 | 0.090 |
Why?
|
Blood Cells | 1 | 2013 | 309 | 0.090 |
Why?
|
Sequence Deletion | 1 | 1995 | 1525 | 0.090 |
Why?
|
Receptor, IGF Type 1 | 1 | 2013 | 390 | 0.090 |
Why?
|
Cytoplasmic Granules | 2 | 2005 | 610 | 0.090 |
Why?
|
Signal Transduction | 9 | 2012 | 23404 | 0.090 |
Why?
|
Models, Molecular | 3 | 2010 | 5451 | 0.090 |
Why?
|
Macrophages | 3 | 2012 | 5660 | 0.090 |
Why?
|
Molecular Dynamics Simulation | 1 | 2013 | 409 | 0.090 |
Why?
|
Glycosylphosphatidylinositols | 2 | 2009 | 94 | 0.090 |
Why?
|
Receptors, Complement | 1 | 2010 | 264 | 0.090 |
Why?
|
Microscopy, Confocal | 6 | 2012 | 1970 | 0.090 |
Why?
|
Endothelial Cells | 4 | 2012 | 3486 | 0.090 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 1312 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2017 | 1504 | 0.090 |
Why?
|
Uterine Rupture | 1 | 1990 | 72 | 0.090 |
Why?
|
Erythrocyte Aging | 1 | 2009 | 52 | 0.090 |
Why?
|
Complement System Proteins | 1 | 2013 | 795 | 0.090 |
Why?
|
Leukocytes | 2 | 2008 | 2045 | 0.090 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2011 | 482 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 1996 | 2027 | 0.090 |
Why?
|
Neutrophils | 2 | 2006 | 3721 | 0.090 |
Why?
|
Rotation | 3 | 1996 | 523 | 0.090 |
Why?
|
Cholesterol | 4 | 1996 | 2919 | 0.080 |
Why?
|
Molecular Conformation | 2 | 2010 | 562 | 0.080 |
Why?
|
Retinoblastoma Protein | 1 | 2013 | 705 | 0.080 |
Why?
|
Genes, BRCA1 | 1 | 2013 | 781 | 0.080 |
Why?
|
Phosphoproteins | 2 | 2008 | 2441 | 0.080 |
Why?
|
Spherocytosis, Hereditary | 2 | 1999 | 80 | 0.080 |
Why?
|
Biological Evolution | 1 | 2015 | 1077 | 0.080 |
Why?
|
Computer Simulation | 2 | 2014 | 6194 | 0.080 |
Why?
|
Luminescent Proteins | 2 | 2003 | 853 | 0.080 |
Why?
|
Hydrogen Peroxide | 1 | 2012 | 730 | 0.080 |
Why?
|
Oocytes | 1 | 1994 | 1188 | 0.080 |
Why?
|
RNA Precursors | 1 | 2010 | 209 | 0.080 |
Why?
|
Cytomegalovirus Infections | 2 | 2013 | 820 | 0.080 |
Why?
|
Capillary Permeability | 1 | 2012 | 798 | 0.080 |
Why?
|
Virus Diseases | 1 | 2015 | 711 | 0.080 |
Why?
|
Optical Tweezers | 1 | 2009 | 79 | 0.080 |
Why?
|
Aminoglycosides | 1 | 2009 | 162 | 0.080 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 850 | 0.080 |
Why?
|
Microspheres | 2 | 2010 | 777 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4479 | 0.080 |
Why?
|
Membrane Glycoproteins | 4 | 1994 | 3771 | 0.080 |
Why?
|
Protein Deficiency | 1 | 2008 | 61 | 0.080 |
Why?
|
Molecular Mimicry | 1 | 2009 | 201 | 0.080 |
Why?
|
CDC2 Protein Kinase | 1 | 2009 | 220 | 0.080 |
Why?
|
Vault Ribonucleoprotein Particles | 1 | 2007 | 11 | 0.080 |
Why?
|
Likelihood Functions | 1 | 2011 | 1005 | 0.080 |
Why?
|
Lipoproteins, LDL | 1 | 1991 | 640 | 0.080 |
Why?
|
Chlorides | 2 | 2009 | 667 | 0.080 |
Why?
|
Heterozygote | 2 | 2013 | 2804 | 0.080 |
Why?
|
Transferases | 1 | 2007 | 75 | 0.070 |
Why?
|
Exodeoxyribonucleases | 1 | 2008 | 180 | 0.070 |
Why?
|
COS Cells | 3 | 2005 | 1161 | 0.070 |
Why?
|
Leiomyoma | 2 | 1990 | 730 | 0.070 |
Why?
|
Transfection | 7 | 2005 | 5895 | 0.070 |
Why?
|
Cortactin | 1 | 2006 | 31 | 0.070 |
Why?
|
Complement Activation | 1 | 2009 | 453 | 0.070 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 2006 | 40 | 0.070 |
Why?
|
Interferon-gamma | 3 | 1996 | 3207 | 0.070 |
Why?
|
Photobleaching | 1 | 2006 | 31 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2014 | 21748 | 0.070 |
Why?
|
DNA | 3 | 2012 | 7294 | 0.070 |
Why?
|
Corneal Ulcer | 1 | 2008 | 169 | 0.070 |
Why?
|
Cyclic GMP | 1 | 2007 | 409 | 0.070 |
Why?
|
Atrial Natriuretic Factor | 1 | 2007 | 393 | 0.070 |
Why?
|
Protein Structure, Tertiary | 2 | 2012 | 3848 | 0.070 |
Why?
|
Markov Chains | 1 | 2010 | 969 | 0.070 |
Why?
|
Fluoresceins | 3 | 1995 | 235 | 0.070 |
Why?
|
Antigens, CD | 5 | 2008 | 4026 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 4 | 2012 | 2505 | 0.070 |
Why?
|
Placenta Accreta | 1 | 1990 | 225 | 0.070 |
Why?
|
Subcellular Fractions | 2 | 2004 | 547 | 0.070 |
Why?
|
Antibody Affinity | 1 | 2006 | 254 | 0.070 |
Why?
|
Genetic Testing | 1 | 2019 | 3444 | 0.070 |
Why?
|
Calpain | 1 | 2006 | 150 | 0.070 |
Why?
|
Receptors, Interleukin-1 | 1 | 2007 | 262 | 0.070 |
Why?
|
Surface Plasmon Resonance | 1 | 2006 | 274 | 0.070 |
Why?
|
Photochemistry | 3 | 1996 | 238 | 0.070 |
Why?
|
Stress, Physiological | 2 | 2005 | 1403 | 0.070 |
Why?
|
RNA, Messenger | 5 | 2009 | 13035 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2008 | 675 | 0.060 |
Why?
|
Antigen-Presenting Cells | 3 | 2006 | 973 | 0.060 |
Why?
|
Epithelium, Corneal | 1 | 2008 | 247 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2703 | 0.060 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2008 | 486 | 0.060 |
Why?
|
Eye Infections, Bacterial | 1 | 2008 | 235 | 0.060 |
Why?
|
Xanthenes | 2 | 1995 | 73 | 0.060 |
Why?
|
Fluorescence Resonance Energy Transfer | 2 | 2005 | 401 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6459 | 0.060 |
Why?
|
Protein Conformation | 3 | 2006 | 4010 | 0.060 |
Why?
|
Ion Channel Gating | 2 | 1999 | 437 | 0.060 |
Why?
|
Hemolysis | 1 | 1986 | 420 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 1991 | 906 | 0.060 |
Why?
|
Caveolins | 1 | 2004 | 104 | 0.060 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2005 | 190 | 0.060 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 1941 | 0.060 |
Why?
|
Green Fluorescent Proteins | 3 | 2008 | 2088 | 0.060 |
Why?
|
Cations | 2 | 2002 | 232 | 0.060 |
Why?
|
Type C Phospholipases | 1 | 2004 | 292 | 0.060 |
Why?
|
Mice | 18 | 2015 | 81201 | 0.060 |
Why?
|
Cadherins | 1 | 2008 | 907 | 0.060 |
Why?
|
Acceleration | 1 | 2004 | 181 | 0.060 |
Why?
|
Intracellular Fluid | 1 | 2003 | 203 | 0.060 |
Why?
|
Uterine Neoplasms | 2 | 1990 | 1513 | 0.060 |
Why?
|
Mitochondrial Swelling | 1 | 2002 | 17 | 0.060 |
Why?
|
Vasodilator Agents | 1 | 2007 | 976 | 0.060 |
Why?
|
Erythropoietin | 1 | 2008 | 726 | 0.060 |
Why?
|
RNA Stability | 1 | 2005 | 321 | 0.060 |
Why?
|
Phosphatidic Acids | 2 | 1994 | 49 | 0.050 |
Why?
|
HeLa Cells | 5 | 2011 | 3130 | 0.050 |
Why?
|
Tandem Mass Spectrometry | 1 | 2009 | 1157 | 0.050 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2006 | 1159 | 0.050 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1120 | 0.050 |
Why?
|
Ribonucleoproteins | 1 | 2005 | 381 | 0.050 |
Why?
|
Immunosuppressive Agents | 2 | 2006 | 4153 | 0.050 |
Why?
|
Immunity, Innate | 3 | 2009 | 2962 | 0.050 |
Why?
|
Polymerization | 2 | 2013 | 164 | 0.050 |
Why?
|
Pedigree | 3 | 2016 | 4642 | 0.050 |
Why?
|
Binding Sites | 3 | 2013 | 6111 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2003 | 1081 | 0.050 |
Why?
|
Respiratory Tract Infections | 1 | 2009 | 961 | 0.050 |
Why?
|
Carbocyanines | 3 | 1996 | 174 | 0.050 |
Why?
|
Hydroxyurea | 2 | 2007 | 289 | 0.050 |
Why?
|
RNA, Messenger, Stored | 1 | 2000 | 6 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2012 | 3084 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2007 | 972 | 0.050 |
Why?
|
Liposomes | 3 | 1996 | 759 | 0.050 |
Why?
|
Immunoblotting | 4 | 2012 | 1683 | 0.050 |
Why?
|
Viral Proteins | 1 | 2008 | 1900 | 0.050 |
Why?
|
Cell Size | 2 | 1993 | 643 | 0.050 |
Why?
|
Antibodies, Monoclonal | 8 | 1996 | 9274 | 0.050 |
Why?
|
Stress, Mechanical | 2 | 2015 | 1686 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2007 | 1351 | 0.050 |
Why?
|
Feedback | 1 | 2004 | 795 | 0.050 |
Why?
|
Ion Transport | 3 | 1999 | 320 | 0.050 |
Why?
|
Mice, Inbred Strains | 2 | 2007 | 1828 | 0.050 |
Why?
|
Infant Food | 1 | 2000 | 141 | 0.050 |
Why?
|
Escherichia coli Proteins | 1 | 2007 | 1050 | 0.050 |
Why?
|
Lamin Type A | 2 | 2013 | 190 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12952 | 0.040 |
Why?
|
Oligopeptides | 1 | 2005 | 1189 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 3 | 1998 | 688 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2012 | 3589 | 0.040 |
Why?
|
Chloramphenicol | 1 | 1999 | 75 | 0.040 |
Why?
|
Extracellular Space | 1 | 2002 | 595 | 0.040 |
Why?
|
Posture | 1 | 2004 | 958 | 0.040 |
Why?
|
Aniline Compounds | 2 | 1995 | 986 | 0.040 |
Why?
|
RNA-Binding Proteins | 3 | 2011 | 1903 | 0.040 |
Why?
|
Epitopes | 1 | 2006 | 2571 | 0.040 |
Why?
|
Actins | 3 | 2006 | 2121 | 0.040 |
Why?
|
Insulin | 3 | 2008 | 6582 | 0.040 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1999 | 192 | 0.040 |
Why?
|
Cell Nucleus | 4 | 2013 | 2969 | 0.040 |
Why?
|
Aquaporin 1 | 1 | 1999 | 58 | 0.040 |
Why?
|
Integrin alpha Chains | 1 | 1999 | 97 | 0.040 |
Why?
|
Rhodamines | 2 | 1991 | 183 | 0.040 |
Why?
|
Phenotype | 3 | 2014 | 16367 | 0.040 |
Why?
|
Eosine Yellowish-(YS) | 1 | 1998 | 72 | 0.040 |
Why?
|
Receptors, Bradykinin | 1 | 1998 | 19 | 0.040 |
Why?
|
Electromyography | 1 | 2004 | 1379 | 0.040 |
Why?
|
Hand | 1 | 2004 | 884 | 0.040 |
Why?
|
Osteoblasts | 1 | 2004 | 1166 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2007 | 3873 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2005 | 3511 | 0.040 |
Why?
|
Cell Line, Transformed | 2 | 2012 | 898 | 0.040 |
Why?
|
Antigens, Bacterial | 2 | 1995 | 1172 | 0.040 |
Why?
|
Ceramides | 1 | 1999 | 199 | 0.040 |
Why?
|
Bradykinin | 1 | 1998 | 214 | 0.040 |
Why?
|
Laminin | 1 | 2000 | 419 | 0.040 |
Why?
|
Salmonella typhi | 1 | 2000 | 201 | 0.040 |
Why?
|
Mitochondria | 2 | 2002 | 3514 | 0.040 |
Why?
|
Erythroblasts | 1 | 1998 | 150 | 0.040 |
Why?
|
Asia, Southeastern | 2 | 1995 | 111 | 0.040 |
Why?
|
Software | 1 | 2012 | 4441 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2019 | 279 | 0.040 |
Why?
|
NF-kappa B | 2 | 2007 | 2499 | 0.040 |
Why?
|
Cricetinae | 3 | 2004 | 2475 | 0.040 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 1998 | 175 | 0.040 |
Why?
|
Membrane Potentials | 3 | 2002 | 1137 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2002 | 2216 | 0.040 |
Why?
|
Blood Group Antigens | 1 | 1999 | 180 | 0.040 |
Why?
|
Hemoglobin SC Disease | 1 | 1996 | 22 | 0.040 |
Why?
|
Interleukin-2 | 3 | 2004 | 1904 | 0.040 |
Why?
|
Enzyme Activation | 5 | 2004 | 3702 | 0.040 |
Why?
|
Antigen-Antibody Reactions | 2 | 1995 | 363 | 0.040 |
Why?
|
Eye Color | 1 | 2016 | 36 | 0.040 |
Why?
|
Lung Diseases | 1 | 2007 | 1887 | 0.040 |
Why?
|
Graft vs Host Disease | 3 | 1991 | 2958 | 0.040 |
Why?
|
Down-Regulation | 1 | 2004 | 3001 | 0.040 |
Why?
|
Cell Survival | 2 | 1997 | 5882 | 0.040 |
Why?
|
Ferritins | 1 | 1999 | 590 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 1999 | 498 | 0.040 |
Why?
|
Heinz Bodies | 1 | 1996 | 5 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 2 | 1993 | 1475 | 0.040 |
Why?
|
Lasers | 1 | 2001 | 952 | 0.030 |
Why?
|
Vanadates | 1 | 1996 | 82 | 0.030 |
Why?
|
Potassium | 3 | 1999 | 1336 | 0.030 |
Why?
|
Exocytosis | 2 | 1995 | 354 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 288 | 0.030 |
Why?
|
P-Selectin | 2 | 1995 | 601 | 0.030 |
Why?
|
Hair Color | 1 | 2016 | 136 | 0.030 |
Why?
|
Leukotriene D4 | 1 | 1995 | 38 | 0.030 |
Why?
|
Nonmuscle Myosin Type IIA | 1 | 2015 | 26 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 1996 | 180 | 0.030 |
Why?
|
Antigens, Surface | 2 | 1991 | 1663 | 0.030 |
Why?
|
Fluorescence | 2 | 1996 | 751 | 0.030 |
Why?
|
Peptide Fragments | 2 | 2007 | 5096 | 0.030 |
Why?
|
Diphosphates | 1 | 1995 | 88 | 0.030 |
Why?
|
Glass | 1 | 1996 | 114 | 0.030 |
Why?
|
Hemorheology | 1 | 1996 | 145 | 0.030 |
Why?
|
RNA Processing, Post-Transcriptional | 2 | 2011 | 436 | 0.030 |
Why?
|
Erythrocyte Deformability | 1 | 1995 | 56 | 0.030 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1996 | 189 | 0.030 |
Why?
|
Receptor, Insulin | 2 | 2004 | 847 | 0.030 |
Why?
|
Leukotriene C4 | 1 | 1995 | 97 | 0.030 |
Why?
|
Mutation | 4 | 2015 | 29786 | 0.030 |
Why?
|
Lumicolchicines | 1 | 1994 | 3 | 0.030 |
Why?
|
Cytosol | 2 | 1998 | 901 | 0.030 |
Why?
|
Cytochalasins | 1 | 1994 | 19 | 0.030 |
Why?
|
Peptide Library | 2 | 2007 | 349 | 0.030 |
Why?
|
von Willebrand Factor | 2 | 1995 | 669 | 0.030 |
Why?
|
Catalysis | 2 | 2007 | 762 | 0.030 |
Why?
|
Fetal Viability | 1 | 1994 | 31 | 0.030 |
Why?
|
Drosophila Proteins | 1 | 2003 | 1703 | 0.030 |
Why?
|
Radioligand Assay | 1 | 1994 | 374 | 0.030 |
Why?
|
Bone Marrow Cells | 2 | 2012 | 2513 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 1987 | 4666 | 0.030 |
Why?
|
Motor Activity | 1 | 2004 | 2715 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 1999 | 727 | 0.030 |
Why?
|
Caffeine | 1 | 1998 | 699 | 0.030 |
Why?
|
RNA Viruses | 1 | 2015 | 124 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1995 | 343 | 0.030 |
Why?
|
Aorta | 3 | 2012 | 2062 | 0.030 |
Why?
|
Centrifugation, Zonal | 1 | 1993 | 14 | 0.030 |
Why?
|
Polyribosomes | 2 | 2005 | 110 | 0.030 |
Why?
|
Lymphoma, T-Cell | 1 | 1996 | 299 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9340 | 0.030 |
Why?
|
Bacillus subtilis | 2 | 2007 | 359 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 23336 | 0.030 |
Why?
|
Mesocricetus | 1 | 1993 | 252 | 0.030 |
Why?
|
Population Dynamics | 1 | 2015 | 302 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1995 | 1454 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2012 | 4208 | 0.030 |
Why?
|
Biological Transport, Active | 1 | 1993 | 349 | 0.030 |
Why?
|
Fatty Acids | 1 | 2000 | 1809 | 0.030 |
Why?
|
Lymphocytes | 1 | 2000 | 2617 | 0.030 |
Why?
|
Plasma | 1 | 1996 | 575 | 0.030 |
Why?
|
Breast Feeding | 1 | 2000 | 1338 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2007 | 1802 | 0.030 |
Why?
|
Time Factors | 6 | 2011 | 40075 | 0.030 |
Why?
|
Electrophoresis | 1 | 2012 | 240 | 0.030 |
Why?
|
Motion | 1 | 1996 | 798 | 0.030 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2012 | 193 | 0.030 |
Why?
|
Ribonucleoprotein, U1 Small Nuclear | 1 | 2011 | 36 | 0.030 |
Why?
|
Thrombin | 1 | 1994 | 598 | 0.030 |
Why?
|
Bone Marrow Purging | 1 | 1991 | 109 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2002 | 1832 | 0.030 |
Why?
|
Rats | 4 | 1997 | 24252 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 1995 | 498 | 0.020 |
Why?
|
Spliceosomes | 1 | 2011 | 110 | 0.020 |
Why?
|
Jews | 1 | 2013 | 385 | 0.020 |
Why?
|
Microcirculation | 1 | 1996 | 1287 | 0.020 |
Why?
|
Genome, Viral | 1 | 2015 | 667 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2013 | 513 | 0.020 |
Why?
|
Embryonic Development | 1 | 1996 | 711 | 0.020 |
Why?
|
Cyclic AMP | 1 | 1995 | 1472 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2307 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 1992 | 471 | 0.020 |
Why?
|
Transforming Growth Factors | 1 | 1990 | 76 | 0.020 |
Why?
|
TRPM Cation Channels | 1 | 2011 | 140 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 1994 | 531 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2011 | 209 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 2013 | 18111 | 0.020 |
Why?
|
Antibodies | 1 | 1999 | 2460 | 0.020 |
Why?
|
Cloning, Molecular | 2 | 2007 | 4320 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 1996 | 544 | 0.020 |
Why?
|
Serine | 2 | 2006 | 826 | 0.020 |
Why?
|
Erythrocyte Count | 1 | 2010 | 163 | 0.020 |
Why?
|
Mechanotransduction, Cellular | 1 | 2015 | 541 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2005 | 2050 | 0.020 |
Why?
|
Puerperal Infection | 1 | 1990 | 46 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1996 | 985 | 0.020 |
Why?
|
Casein Kinase II | 1 | 2010 | 128 | 0.020 |
Why?
|
4-Chloro-7-nitrobenzofurazan | 2 | 1996 | 19 | 0.020 |
Why?
|
TRPC Cation Channels | 1 | 2010 | 121 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1152 | 0.020 |
Why?
|
Haplotypes | 1 | 2016 | 2779 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 1993 | 1247 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2011 | 344 | 0.020 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1992 | 473 | 0.020 |
Why?
|
Antigen Presentation | 1 | 1995 | 1284 | 0.020 |
Why?
|
Cytoplasm | 1 | 1994 | 1536 | 0.020 |
Why?
|
Ribonuclease III | 1 | 2011 | 275 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 1996 | 1701 | 0.020 |
Why?
|
Base Sequence | 3 | 2013 | 12797 | 0.020 |
Why?
|
Female | 13 | 2013 | 380193 | 0.020 |
Why?
|
Chemotaxis | 1 | 2012 | 607 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2004 | 5856 | 0.020 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2010 | 250 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 5749 | 0.020 |
Why?
|
Autoantigens | 1 | 1993 | 892 | 0.020 |
Why?
|
Blotting, Western | 2 | 2008 | 5181 | 0.020 |
Why?
|
Ribonucleosides | 1 | 2009 | 82 | 0.020 |
Why?
|
Wound Healing | 1 | 2000 | 2785 | 0.020 |
Why?
|
Catenins | 1 | 2008 | 41 | 0.020 |
Why?
|
Phalloidine | 1 | 1988 | 21 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2013 | 20824 | 0.020 |
Why?
|
Amino Acid Sequence | 4 | 2007 | 13814 | 0.020 |
Why?
|
Microtubules | 1 | 1994 | 1089 | 0.020 |
Why?
|
Meningitis | 1 | 1990 | 216 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2011 | 811 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 1994 | 2184 | 0.020 |
Why?
|
Intracellular Membranes | 2 | 2002 | 391 | 0.020 |
Why?
|
beta-Cyclodextrins | 1 | 2008 | 64 | 0.020 |
Why?
|
Melanocytes | 1 | 2011 | 515 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2008 | 300 | 0.020 |
Why?
|
Phosphatidylcholines | 2 | 1996 | 411 | 0.020 |
Why?
|
Thiocyanates | 1 | 1987 | 70 | 0.020 |
Why?
|
Transcription Factors | 2 | 2005 | 12207 | 0.020 |
Why?
|
Postoperative Complications | 1 | 1990 | 15297 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2008 | 331 | 0.020 |
Why?
|
Nitric Oxide | 2 | 2007 | 2132 | 0.020 |
Why?
|
Action Potentials | 1 | 1995 | 1806 | 0.020 |
Why?
|
Half-Life | 1 | 2008 | 661 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2428 | 0.020 |
Why?
|
Toll-Like Receptor 5 | 1 | 2007 | 39 | 0.020 |
Why?
|
Genetic Loci | 1 | 2016 | 2575 | 0.020 |
Why?
|
Diptera | 1 | 2007 | 53 | 0.020 |
Why?
|
Paclitaxel | 1 | 1994 | 1708 | 0.020 |
Why?
|
Cell Separation | 1 | 1993 | 1751 | 0.020 |
Why?
|
Antisickling Agents | 1 | 2007 | 80 | 0.020 |
Why?
|
Gap Junctions | 1 | 2008 | 233 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2005 | 1723 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9647 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2890 | 0.020 |
Why?
|
Osmolar Concentration | 2 | 1994 | 683 | 0.020 |
Why?
|
Bacterial Adhesion | 1 | 2008 | 316 | 0.020 |
Why?
|
Male | 10 | 2013 | 350115 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2013 | 19905 | 0.020 |
Why?
|
Megakaryocytes | 1 | 1990 | 545 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 1999 | 3390 | 0.020 |
Why?
|
Sodium Chloride | 1 | 2008 | 625 | 0.020 |
Why?
|
Cell Communication | 1 | 1993 | 1621 | 0.020 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1988 | 255 | 0.020 |
Why?
|
Interleukin-6 | 1 | 1996 | 3203 | 0.020 |
Why?
|
Protein Biosynthesis | 2 | 2005 | 2126 | 0.020 |
Why?
|
Cytokines | 1 | 2000 | 7323 | 0.020 |
Why?
|
Endothelium | 1 | 2008 | 778 | 0.020 |
Why?
|
Streptococcal Infections | 1 | 1990 | 638 | 0.020 |
Why?
|
Reference Values | 1 | 1993 | 4982 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2004 | 10943 | 0.020 |
Why?
|
Adult | 8 | 2013 | 214052 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1998 | 4386 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2012 | 16690 | 0.020 |
Why?
|
Mitosis | 1 | 1990 | 1208 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2010 | 5974 | 0.020 |
Why?
|
Biotin | 1 | 2006 | 254 | 0.020 |
Why?
|
Phagocytosis | 1 | 2010 | 1539 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2007 | 354 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2013 | 57776 | 0.020 |
Why?
|
Information Dissemination | 1 | 2013 | 1099 | 0.020 |
Why?
|
Transferrin | 1 | 2005 | 295 | 0.020 |
Why?
|
Immune Tolerance | 1 | 1993 | 2259 | 0.020 |
Why?
|
Cicatrix | 1 | 1990 | 764 | 0.010 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2004 | 129 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1993 | 2455 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2006 | 551 | 0.010 |
Why?
|
Uterus | 1 | 1988 | 711 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 2006 | 3799 | 0.010 |
Why?
|
Benzimidazoles | 1 | 2009 | 850 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 1991 | 2765 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2007 | 565 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2004 | 459 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1991 | 1837 | 0.010 |
Why?
|
Calcineurin | 1 | 2004 | 226 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2000 | 4424 | 0.010 |
Why?
|
Organic Chemicals | 1 | 2004 | 211 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1986 | 694 | 0.010 |
Why?
|
Ruthenium Red | 1 | 2002 | 19 | 0.010 |
Why?
|
Skin Diseases | 1 | 1991 | 1066 | 0.010 |
Why?
|
Calcimycin | 1 | 2002 | 222 | 0.010 |
Why?
|
Myristic Acid | 1 | 2002 | 47 | 0.010 |
Why?
|
Ionophores | 1 | 2002 | 108 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 2002 | 128 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 480 | 0.010 |
Why?
|
Blood Bactericidal Activity | 1 | 2002 | 126 | 0.010 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2007 | 571 | 0.010 |
Why?
|
Oxadiazoles | 1 | 1982 | 93 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 489 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2015 | 2987 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6539 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2004 | 381 | 0.010 |
Why?
|
Sphingosine | 1 | 2004 | 307 | 0.010 |
Why?
|
Tyrosine | 1 | 2006 | 1462 | 0.010 |
Why?
|
Molecular Weight | 2 | 1996 | 2255 | 0.010 |
Why?
|
Lysophospholipids | 1 | 2004 | 331 | 0.010 |
Why?
|
Palmitic Acid | 1 | 2002 | 154 | 0.010 |
Why?
|
Dimyristoylphosphatidylcholine | 2 | 1996 | 26 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2002 | 829 | 0.010 |
Why?
|
Albumins | 1 | 2004 | 568 | 0.010 |
Why?
|
Cyclosporine | 1 | 2004 | 788 | 0.010 |
Why?
|
Emetine | 1 | 2000 | 15 | 0.010 |
Why?
|
Puromycin | 1 | 2000 | 44 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1999 | 7182 | 0.010 |
Why?
|
HIV-1 | 1 | 1999 | 6939 | 0.010 |
Why?
|
GTP Phosphohydrolases | 1 | 2004 | 508 | 0.010 |
Why?
|
Poly(A)-Binding Proteins | 1 | 2000 | 36 | 0.010 |
Why?
|
Peptides | 1 | 1993 | 4410 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2002 | 964 | 0.010 |
Why?
|
Stearic Acids | 1 | 2000 | 53 | 0.010 |
Why?
|
Virus Replication | 1 | 2009 | 2535 | 0.010 |
Why?
|
Androstadienes | 1 | 2002 | 345 | 0.010 |
Why?
|
Permeability | 1 | 2002 | 738 | 0.010 |
Why?
|
alpha-Linolenic Acid | 1 | 2000 | 144 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2005 | 1793 | 0.010 |
Why?
|
Aconitate Hydratase | 1 | 1999 | 15 | 0.010 |
Why?
|
Temperature | 2 | 1991 | 2204 | 0.010 |
Why?
|
Apoferritins | 1 | 1999 | 18 | 0.010 |
Why?
|
Receptors, Very Late Antigen | 1 | 1999 | 74 | 0.010 |
Why?
|
Iron-Regulatory Proteins | 1 | 1999 | 32 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10483 | 0.010 |
Why?
|
Linoleic Acid | 1 | 2000 | 157 | 0.010 |
Why?
|
Lymphocyte Depletion | 2 | 1991 | 608 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1998 | 12073 | 0.010 |
Why?
|
Caspases | 1 | 2002 | 928 | 0.010 |
Why?
|
Iron-Sulfur Proteins | 1 | 1999 | 82 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1284 | 0.010 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2000 | 227 | 0.010 |
Why?
|
Hybridomas | 2 | 1992 | 452 | 0.010 |
Why?
|
Receptor, Bradykinin B2 | 1 | 1998 | 24 | 0.010 |
Why?
|
Ryanodine | 1 | 1998 | 47 | 0.010 |
Why?
|
Muridae | 1 | 1998 | 61 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1998 | 6171 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2007 | 1161 | 0.010 |
Why?
|
Microsomes | 1 | 1998 | 257 | 0.010 |
Why?
|
Lung | 2 | 2007 | 9857 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2007 | 14561 | 0.010 |
Why?
|
Concanavalin A | 1 | 1998 | 191 | 0.010 |
Why?
|
Necrosis | 1 | 2002 | 1643 | 0.010 |
Why?
|
Aged | 3 | 2013 | 163288 | 0.010 |
Why?
|
Cell Division | 2 | 1999 | 4569 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 429 | 0.010 |
Why?
|
K562 Cells | 1 | 1999 | 635 | 0.010 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2000 | 546 | 0.010 |
Why?
|
United States | 2 | 2017 | 69872 | 0.010 |
Why?
|
Cell Membrane Permeability | 1 | 1999 | 590 | 0.010 |
Why?
|
Plasmids | 1 | 2002 | 2308 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 8432 | 0.010 |
Why?
|
Pregnancy | 4 | 1996 | 29144 | 0.010 |
Why?
|
S Phase | 1 | 1998 | 423 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2000 | 1263 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 1999 | 659 | 0.010 |
Why?
|
Dimerization | 1 | 1998 | 895 | 0.010 |
Why?
|
Middle Aged | 3 | 2013 | 213390 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1997 | 378 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18373 | 0.010 |
Why?
|
Lymphocyte Cooperation | 1 | 1995 | 112 | 0.010 |
Why?
|
Gene Targeting | 1 | 1999 | 880 | 0.010 |
Why?
|
Ethanolamines | 1 | 1996 | 158 | 0.010 |
Why?
|
Dogs | 1 | 2000 | 3912 | 0.010 |
Why?
|
Escherichia coli | 1 | 2007 | 4217 | 0.010 |
Why?
|
Surface Properties | 1 | 1997 | 1184 | 0.010 |
Why?
|
Phosphatidylserines | 1 | 1996 | 193 | 0.010 |
Why?
|
Pyrimidines | 1 | 2006 | 2943 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 1995 | 462 | 0.010 |
Why?
|
Fetal Hemoglobin | 1 | 1996 | 341 | 0.010 |
Why?
|
Docosahexaenoic Acids | 1 | 2000 | 875 | 0.010 |
Why?
|
Sodium | 1 | 1999 | 1622 | 0.010 |
Why?
|
Electroporation | 1 | 1995 | 251 | 0.010 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 1994 | 293 | 0.010 |
Why?
|
Kidney | 2 | 2000 | 7184 | 0.010 |
Why?
|
Circular Dichroism | 1 | 1993 | 354 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2006 | 5023 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1993 | 1157 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1998 | 2649 | 0.010 |
Why?
|
Enterotoxins | 1 | 1993 | 368 | 0.010 |
Why?
|
Video Recording | 1 | 1996 | 949 | 0.010 |
Why?
|
Blood Protein Electrophoresis | 1 | 1990 | 73 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2000 | 1344 | 0.010 |
Why?
|
DNA Replication | 1 | 1998 | 1399 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 1991 | 448 | 0.010 |
Why?
|
Glycolipids | 1 | 1991 | 204 | 0.010 |
Why?
|
Phosphatidylinositols | 1 | 1991 | 291 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 1999 | 21833 | 0.010 |
Why?
|
Ligands | 1 | 1997 | 3282 | 0.010 |
Why?
|
CHO Cells | 1 | 1993 | 1409 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1999 | 2232 | 0.010 |
Why?
|
Hemoglobins | 1 | 1996 | 1532 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1801 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18034 | 0.010 |
Why?
|
Streptococcus agalactiae | 1 | 1990 | 375 | 0.000 |
Why?
|
Lymphoproliferative Disorders | 1 | 1991 | 524 | 0.000 |
Why?
|
Cell Differentiation | 2 | 1998 | 11486 | 0.000 |
Why?
|
Obstetric Labor, Premature | 1 | 1988 | 279 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1996 | 3759 | 0.000 |
Why?
|
Apoptosis | 1 | 2002 | 9724 | 0.000 |
Why?
|
Antigens, Differentiation | 1 | 1989 | 927 | 0.000 |
Why?
|
Puerperal Disorders | 1 | 1988 | 275 | 0.000 |
Why?
|
Spleen | 1 | 1991 | 2362 | 0.000 |
Why?
|
Immunoenzyme Techniques | 1 | 1988 | 1799 | 0.000 |
Why?
|
Staphylococcus aureus | 1 | 1993 | 1453 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1998 | 7721 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2000 | 8949 | 0.000 |
Why?
|
Leukemia | 1 | 1991 | 1510 | 0.000 |
Why?
|
Skin | 1 | 1996 | 4372 | 0.000 |
Why?
|
Graft Survival | 1 | 1991 | 3737 | 0.000 |
Why?
|
Infant | 1 | 2000 | 35134 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2000 | 11126 | 0.000 |
Why?
|
Ultrasonography | 1 | 1988 | 5984 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1988 | 11366 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 1988 | 13991 | 0.000 |
Why?
|
Prospective Studies | 1 | 1988 | 53290 | 0.000 |
Why?
|
Adolescent | 1 | 1991 | 85779 | 0.000 |
Why?
|